| Disease |
| Leishmaniasis |
Species |
Patient |
Reservoir |
Vector |
| Old Localized Cutaneous |
L. major (moist) L. tropica (dry) |
Human |
Dog, rodent |
Phlebotomus spp (Sandfly) |
| New Cutaneous |
L. mexicana |
Human |
Dog, rodent |
Phlebotomus spp (Sandfly) |
| Diffuse Cutaneous |
L. aethiopica |
Human |
Hyrax |
Phlebotomus spp (Sandfly) |
| New Dry Cutaneous |
L. amazonensis |
Human |
Dog, rodent. |
Lutzomyia |
| Muco-Cutaneous |
L. braziliensis L. guyanensis (both viannia) |
Human |
Dog, rodent. |
Phlebotomus spp (Sandfly) |
| Visceral |
L. donovani |
Human |
Human |
Phlebotomus spp (Sandfly) |
| Visceral |
L. infantum |
None, zoonosis |
Dogs |
Phlebotomus spp (Sandfly) |
| Leishmania/HIV |
Co-infection is an emerging disease, particularly in southern Europe where 25-70% of adult Visceral Leishmaniasis are related to HIV infection, and 1.5-9.5% of AIDS cases suffer from from newly acquired or reactivated Visceral Leishmaniasis. |
|
|
|
|
|
|
|
|
|
|
| Parasite |
Distribution |
| L. tropica |
Urban areas of Mediterranean, Middle East, Pakistan and parts of India. |
| L. major |
Rural (esp desert) areas of Central Asia, South Russia, Middle East and Africa. |
| Parasite |
Distribution |
L. braziliensis L. mexicana |
Central and South America. |
| L. infantum |
Africa, Asia and South Europe. |
| L. chagasi |
South America |
|
|
|
|
|